FDA Inspection
Bausch & Lomb IncorporatedBausch & Lomb Incorporated – FDA Inspection, Nov 25, 2019
Record Details
This FDA Inspection record concerns Bausch & Lomb Incorporated, with an inspection on November 25, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Bausch & Lomb Incorporated
- Inspection Date
- November 25, 2019
- Product Type
- Drugs
View Company Profile
ID · 34629c71-b64c-4cb5-a6a7-49e7d9204a77
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1110911
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.58Buildings not maintained in good state of repair
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Bausch & Lomb Incorporated
10| Date | Classification | Office | Project area |
|---|---|---|---|
| July 30, 2025 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 9, 2024 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| February 23, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| August 18, 2017 | Not classified | New York District Office | |
| March 24, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bausch & Lomb Incorporated
- FDA Inspection 1282260 - 2025-07-30
- FDA Inspection 1250019 - 2024-09-09
- FDA Inspection 1042701 - 2018-02-23
- FDA Inspection 1042383 - 2017-08-18
- FDA Inspection 1007875 - 2017-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.